Clients/Industries

A Representative Sampling Of The Types Of Clients And Industries We Represent

Here is a representative sampling of the types of clients we represent as well as the industries that we work with.

Clients

  • Sole proprietorships
  • Partnerships
  • Private, professional and publicly traded corporations
  • Entrepreneurial ventures
  • Growth-oriented companies
  • Fortune 500 corporations
  • Hospitals and other health care providers
  • Non-profit institutions
  • Major public and private employee benefit trusts
  • Government entities
  • Executives and other individuals


Industries

  • Agriculture
  • Apparel
  • Automotive
  • Benefits Administration
  • Biotechnology
  • Computing
  • Communications
  • Construction
  • Consumer Services
  • Distribution
  • Education
  • Energy
  • Entertainment
  • Environmental
  • Executive Recruiting/Employment Services
  • Financial Services
  • Government
  • Health Care
  • Hi-Tech
  • Insurance
  • Manufacturing
  • Publishing
  • Resource Management
  • Restaurant/Hospitality
  • Retail
  • Transportation
  • Utilities

What's Happening @ MHTL?

View All News

MHTL Appoints Charles Desmond to Advisory Board

Murphy, Hesse, Toomey & Lehane is pleased to announce that Dr. Charles F. Desmond, CEO of Inversant and a senior fellow at the New England Board of Higher Education, has accepted an appointment to the MHTL Advisory Board.

Read More

Legal Updates

View All Updates

Hazy Guidance for Employers: Attorney General Sessions Issues Marijuana Enforcement Memorandum to Federal Prosecutors

On January 4, 2018, Attorney General Jefferson Sessions issued a memorandum rescinding several Obama-era policies that discouraged federal prosecutors from pursuing marijuana possession and distribution cases in marijuana legalization states like Massachusetts. The Obama-era policies were backed by a Congressional budget rider that bars the Department of Justice from spending its money prosecuting state backed medical marijuana operations. The amendment will expire later this month, and it is unclear whether Congress will renew it given the Trump administration’s current priorities.

Read More